Filana Therapeutics FLNA
NASDAQ FLNA
$0.65 -0.01 (-0.89%)
As of: Oct 23, 2026 · 3:59 PM EDT

Filana Therapeutics (FLNA) Other Accumulated Expenses (2010 - 2026)

Updated

Filana Therapeutics (FLNA) posted Other Accumulated Expenses of $121,000 for Q2 2026, down 23.9% from $159,000 a year earlier but up 61.3% from the prior quarter.

Analysis

Filana Therapeutics (FLNA) Other Accumulated Expenses (2010 - 2026) Analysis & Trends

At the end of FY2025, Filana Therapeutics' Other Accumulated Expenses came in at $198,000, down 33.8% from FY2024.

  • Annual Other Accumulated Expenses has declined for four consecutive years, though with a five-year compound annual growth rate of 16.1% (FY2020 to FY2025).
  • In prior years, Filana Therapeutics' Other Accumulated Expenses was $299,000 in FY2024 (-22.3%), $385,000 in FY2023 (-21.7%), $492,000 in FY2022 (-22.0%) and $631,000 in FY2021 (+571.3%).
  • Quarterly Other Accumulated Expenses has run from a low of $75,000 in Q1 2026 to a high of $631,000 in Q4 2021 over five years.
  • On a year-over-year basis, Other Accumulated Expenses has declined in each of the last 16 quarters, with an average decline of 25.2% over the last eight quarters.
  • The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q2 2022, with growth of 640.0%; the weakest was Q4 2025, with a decline of 33.8%.
  • According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $75,000 (Q1 2026), $198,000 (Q4 2025) and $226,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Filana Therapeutics 30.53 Mn -340.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 121,000.00
Mar 31, 2026 75,000.00
Dec 31, 2025 198,000.00
Sep 30, 2025 226,000.00
Jun 30, 2025 159,000.00
Mar 31, 2025 113,000.00
Dec 31, 2024 299,000.00
Sep 30, 2024 297,000.00
Jun 30, 2024 228,000.00
Mar 31, 2024 125,000.00
Dec 31, 2023 385,000.00
Sep 30, 2023 391,000.00
Jun 30, 2023 293,000.00
Mar 31, 2023 179,000.00
Dec 31, 2022 492,000.00
Sep 30, 2022 416,000.00
Jun 30, 2022 370,000.00
Mar 31, 2022 261,000.00
Dec 31, 2021 631,000.00
Sep 30, 2021 509,000.00
API Access

Filana Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=FLNA&period=max&api_key=YOUR_API_KEY